• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECKMAN COULTER ACCESS SARS-COV-2 IGG II; IN VITRO DIAGNOSTIC DEVICES: CORONAVIRUS SEROLOGICAL REAGENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECKMAN COULTER ACCESS SARS-COV-2 IGG II; IN VITRO DIAGNOSTIC DEVICES: CORONAVIRUS SEROLOGICAL REAGENTS Back to Search Results
Catalog Number C69057
Device Problem Erratic Results (4059)
Patient Problem Insufficient Information (4580)
Event Date 10/04/2021
Event Type  malfunction  
Manufacturer Narrative
(b)(6).The customer did not provide patient demographics such as age, date of birth, gender, weight, ethnicity or race.The access sars-cov-2 igg ii assay was not returned for evaluation.There were no reports of system issues at the time of the event.There was no report of issues with other assays at the time of the event.No hardware errors or flags were reported in conjunction with the event.In conclusion, the cause of this event cannot be determined with the available information.
 
Event Description
On (b)(6) 2021 the customer reported that questioned erratic covid igg results (access sars-cov-2 igg ii, part number c69057, lot number 124558) was generated on the customer's access 2 (access 2 immunoassay analyzer, part number 81600n and serial number (b)(4)) on (b)(6) 2021 for two patients.The initial results were released from the laboratory.The customer did not report a change to patient care of treatment in connection with this event.The patients were redrawn the next day and results which were discordant to the original results were obtained.The customer then questioned the original results.The customer then retested the original samples and obtained different results.No hardware errors or issues with other assays were reported in conjunction with this event.System performance indicators such as system check, calibration and quality control were passing within specifications at the time of the event.No issues with sample integrity were reported by the customer.Samples were collected and initially tested in lithium heparin gel tubes; and repeat testing was performed using frozen/thawed aliquots of these samples.Samples were centrifuged for 5 minutes at room temperature (centrifugation speed not provided).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCESS SARS-COV-2 IGG II
Type of Device
IN VITRO DIAGNOSTIC DEVICES: CORONAVIRUS SEROLOGICAL REAGENTS
Manufacturer (Section D)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
MDR Report Key12641506
MDR Text Key281922521
Report Number2122870-2021-00167
Device Sequence Number1
Product Code QKO
UDI-Device Identifier15099590742744
UDI-Public(01)15099590742744(17)211031(11)210503(10)124558
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial
Report Date 10/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/15/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2021
Device Catalogue NumberC69057
Device Lot Number124558
Was Device Available for Evaluation? No
Date Manufacturer Received10/12/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-